Kakkon-TO


Indications and Reactions:

Role Indications Reactions
Secondary
Nasopharyngitis 14.4%
Antitussive Therapy 10.2%
Diuretic Therapy 10.2%
Eczema 7.6%
Pain 7.6%
Hypertension 7.2%
Upper Respiratory Tract Inflammation 5.9%
Diabetes Mellitus 5.1%
Drug Use For Unknown Indication 5.1%
Liver Disorder 5.1%
Musculoskeletal Pain 5.1%
Neck Pain 5.1%
Hyperlipidaemia 2.5%
Pneumonia 2.1%
Cervicobrachial Syndrome 1.7%
Colon Cancer 1.3%
Seasonal Allergy 1.3%
Constipation 0.8%
Gastritis 0.8%
Low Density Lipoprotein Increased 0.8%
Interstitial Lung Disease 18.2%
Stevens-johnson Syndrome 18.2%
Urine Colour Abnormal 12.1%
Drug Ineffective 6.1%
Hepatic Function Abnormal 6.1%
Pyrexia 6.1%
Renal Impairment 6.1%
Weight Increased 6.1%
Drug Eruption 3.0%
Drug Rash With Eosinophilia And Systemic Symptoms 3.0%
Eosinophilia 3.0%
Fatigue 3.0%
Haemorrhage Subcutaneous 3.0%
Vomiting 3.0%
White Blood Cell Count Decreased 3.0%
Concomitant
Nasopharyngitis 15.6%
Prophylaxis 15.6%
Hypertension 7.3%
Product Used For Unknown Indication 7.3%
Drug Use For Unknown Indication 5.4%
Osteoporosis 5.4%
Constipation 4.7%
Osteoarthritis 4.2%
Bronchitis 3.6%
Back Pain 3.4%
Rheumatoid Arthritis 3.4%
Gastric Ulcer 3.1%
Gastrointestinal Disorder 3.1%
Trigeminal Neuralgia 3.1%
Gastritis 2.9%
Reflux Oesophagitis 2.9%
Asteatosis 2.5%
Asthma 2.5%
Glycogen Storage Disease Type Ii 2.2%
Behcet's Syndrome 1.9%
Myelodysplastic Syndrome 14.1%
Ventricular Tachycardia 8.5%
Serum Ferritin Increased 7.0%
Interstitial Lung Disease 5.6%
Respiratory Failure 5.6%
Abnormal Behaviour 4.2%
Haemolysis 4.2%
Intracranial Aneurysm 4.2%
Neutropenia 4.2%
Pancytopenia 4.2%
Pneumocystis Jiroveci Pneumonia 4.2%
Pneumonia 4.2%
Pulmonary Haemorrhage 4.2%
Road Traffic Accident 4.2%
Sepsis 4.2%
Viith Nerve Paralysis 4.2%
White Blood Cell Count Decreased 4.2%
Anaemia 2.8%
Blood Aldosterone Decreased 2.8%
Diarrhoea 2.8%

Drug Data